The Central Drugs Standard Control Organization (CDSCO)  has provided drug inspectors training on the relevant areas of current Good Manufacturing Practices (cGMP) in collaboration with US FDA officials. This is being done with the view of the increased exports from India to the United States which rode 32% to US $4.2 billion. India accounts for about 40 per cent of generic and over the counter (OTC) products and 10 per cent of finished dosages used in the US. This is a step towards the new governments initiatives in the life science sector and will be expanded to train officers in different parts of the country.

Pharma Biz